CTRI/2024/09/074424尚未招募2 期
An Open Labelled Randomised Controlled clinical study to evaluate the safety and efficacy of Qurs-e-Luk in cases of Fart-e-Tadassum fid-dam (Hyperlipidemia)
PG Dept. of Moalijat1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年10月5日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- To reduce the abnormal elevated range of Triglycerides,serum LDL and VLDL cholesterol, serum total Cholesterol.and maintain normal HDL Cholesterol up to 50mg/dl.
研究概览
简要总结
Hyperlipidemia is one of the most important risk factor of Heart attack and stroke, it affects about 75-85% in the control population of comparable age. It impacts on patient health & social life which effect very badly.
My aim to evaluate the therapeutic efficacy of formulated Unani drug and relief the nature of the disease.
Management of Hyperlipidemia with sample size of 40 and 2 months treatment with some inclusion and exclusion criteria ( mentioned in part 6).
The study has been planned.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Diagnosed cases of primary hyperlipidemia is selected for this clinical trial .
- •2.Patient with Serum Triglycerides (TG) more than 200-499 mg/dl , and Serum LDL Cholestrol more than 160-189 mg/dl, Serum Total Cholestrol more than 240 mg/dl,and VLDL less than30mg/dl.
- •HDL Cholestrol up to 50 mg/dl included in this study.
排除标准
- •1.Pregnant & Lactating women 2.Severe active coronary artery disease & Ischemic Heart disease.
- •Uncontrolled DM 4.Alcoholism 5.Mentally retarded patients.
- •6.Patients with severe systemic disease & organ failure.
结局指标
主要结局
To reduce the abnormal elevated range of Triglycerides,serum LDL and VLDL cholesterol, serum total Cholesterol.and maintain normal HDL Cholesterol up to 50mg/dl.
时间窗: once in 2 weeks
次要结局
- To maintain body weight, and reduce the risk factor of cardiovascular diseases.(once in 2 weeks)
研究者
Dr Fareeha Kausar
Govt. Nizamia Tibbi College and General hospital
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A Study to evaluate the efficacy of yogaraja guggulu in Dyslipidemia (Medoroga).CTRI/2024/07/070818Dr Krishna sai P30
尚未招募
3 期
A Clinical Study on the Efficacy of Virechana followed by Bruhat Panchamoola Kashaya in the Management of impaired cholesterol levelsCTRI/2025/03/082027Dr Sai Sudha C S40
尚未招募
2 期
Clinical Evaluation of Siddha Medicine PIRANDAI VADAGAM for Deepana Silathuma Noi (Disorder in lipid profile) (DYSLIPIDEMIA)CTRI/2024/09/073351Dhildhar T40
已完成
不适用
To study the comparative effect of vachadi yoga and haridradi yoga in the management of dyslipidemia(medodusthi).CTRI/2024/03/063977Dr Sonam Tyaral60
尚未招募
3 期
To Evaluate the effect of Vachaharidradi Ghana Vati in the management of High CholesterolCTRI/2024/09/073699Dr K R Sreeranjani30